Report Shows Drug Development Costs Less than What Companies Say
While the pharmaceutical industry cites a $2.8 billion figure for the price of developing a new drug, a team of [...]
Welltok’s Smith Discusses SDOH
Welltok Consumer Journey Director Jodi Smith in a recent write up published on Modern Healthcare Executive says payers and providers [...]
Report: Conferences Move Forward with Plans Despite Coronavirus Concerns
While HIMSS chose to cancel its major health IT conference amid concerns over the coronavirus, other conferences are keeping their [...]
NHC Stresses Patient Perspective in Value Assessment
As value assessments continue to evolve, it's important to factor in the patient perspective, the National Health Council's (NHC) Eleanor [...]
Cantrell Highlights Updated AMCP Format
Academy of Managed Care Pharmacy (AMCP) CEO Susan Cantrell in a blog post says the AMCP Format 4.1 features new [...]
HIMSS Cancels 2020 Meeting Amid Coronavirus Concerns
In response to recent reports on the coronavirus from the World Health Organization and the Centers for Disease Control and [...]
Survey Offers Insight into How Health Economists Would Change Health Policy
A survey presented last year during the American Society of Health Economists conference offers insight into what kind of health [...]
ICER Launches New Suite of Interactive Tools
The Institute for Clinical and Economic Review (ICER) recently announced a new set of interactive tools that could serve as [...]
Course Correction in Precision Medicine ‘Urgently Needed,’ Cooper, Paneth Say
"A course correction is urgently needed," Loyola University Medical School's Dr. Richard Cooper and Michigan State University's Nigel Paneth write, [...]
Total Health Spending Reached $3.1 Trillion Between 1996-2016, Study Suggests
Total health care spending rose from roughly $1.4 trillion in 1996 to about $3.1 trillion in 2016, a recent study [...]
How Are Rebates Impacting Out-of-Pocket Costs?
Rita Rubin in a recent perspective published on JAMA Network looks at how rebates can influence out-of-pocket costs for prescription [...]
NPC’s Leonard Outlines Findings of Research on Coverage Decisions
National Pharmaceutical Council President and CEO Dan Leonard in a recent write up published on Pharmacy Times outlines some key [...]
Study: List Prices Increase 159% Between 2007-18
A recent article published in JAMA suggests list prices between 2007-2018 increased 159 percent, or 9.1 percent per year, while [...]
Oscar Health’s $3 Drug List Looks to Boost Adherence, Lower Pricing
In an effort to bolster patients' medication adherence while also reducing drug spending, Oscar Health developed the $3 Drug List. [...]
AMCP Foundation Spotlights Cantrell
The AMCP Foundation in a recent post spotlights foundation chair Susan Cantrell, who took leadership of AMCP and the foundation [...]
MAPS Taking ‘Necessary Precautions’ Amid Coronavirus Concerns
The Medical Affairs Professional Society (MAPS) is taking "all necessary precautions to ensure the health and safety" of the attendees [...]
Azar: White House Doesn’t Believe in Price Controls as Researchers Work on Coronavirus Vaccine
Health and Human Services Secretary Alex Azar during recent testimony before Congress regarding the Coronavirus said the Trump administration doesn't [...]
Report: Extended-release Drugs Could be Costing Billions
A recent study published in JAMA Network Open suggests the U.S. health care system could save billions if doctors prescribed [...]
Advance Registration Deadline for AMCP 2020 Nears
The deadline for advance registration for the Academy of Managed Care Pharmacy's (AMCP) annual meeting in Houston is midnight PST [...]
ISPOR Announces Travel Grants for Conferences
The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) announced the availability of travel grants for which members can apply [...]
Researchers Apply Proposed Graphical Framework for Longitudinal Studies
The authors of a recent article published in the Journal of Managed Care & Specialty Pharmacy incorporated a graphical framework [...]
Using RWD for Rare Diseases
OM1's Kathryn Starzyk, senior director of real-world evidence, in a recent tHEORetically Speaking blog post outlines how real-world data tools [...]
Report: FDA Program Leads to Billions in Price Increases
A program launched in 2006 by the Food and Drug Administration (FDA) helped ensure the safety and effectiveness of older [...]
Parents Shocked by Price of Children’s Hormone Drug
The parents of an 8-year-old girl were shocked when they discovered the price for a children's hormone blocker cost about [...]
Blog Post Highlights Tool for Tracking Low-Value Care Spending
A recent PhRMA blog post highlights a new web-based tool by the Research Consortium for Health Care Value Assessment that [...]